Aclarion, Inc.

The momentum for this stock is not very good. Aclarion, Inc. is not a good value stock. Tradey thinks it is not wise to invest in Aclarion, Inc..

News

Aclarion completes first Nociscan exams in LIFEHAB Trial

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Aclarion Added to PRISM Emerging Medical Devices Index

Globe Newswire Company's industry-first technology addresses chronic low back painAclarion secured its first commercial agreement with Michigan's Sheridan Community HospitalPRISM Emerging Medical Devices Index...\n more…

Aclarion, Inc. (NASDAQ:ACON) Sees Large Decrease in Short Interest

Ticker Report Aclarion, Inc. (NASDAQ:ACON - Get Free Report) was the target of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 230,900 shares, a...\n more…

Financial Review: First Choice Healthcare Solutions (OTCMKTS:FCHS) vs. Aclarion (NASDAQ:ACON)

Ticker Report First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) and Aclarion (NASDAQ:ACON - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare...\n more…

Aclarion (NASDAQ:ACON) Given Buy Rating at Ascendiant Capital Markets

Ticker Report Ascendiant Capital Markets reiterated their buy rating on shares of Aclarion (NASDAQ:ACON - Free Report) in a research note published on Monday, Marketbeat.com reports. The brokerage currently has a...\n more…